0:00

So, here's an example.

0:01

This woman actually had 3.

0:03

She had a February 2017, then

0:06

January 2019, and then February 2021.

0:09

She's kind of like on the every 2-year plan.

0:11

Um, 52-year-old with extremely dense breasts.

0:14

Look how dense they are on the MR, you can see.

0:16

Um, and the 3rd round, abbreviated

0:19

MR, you see this small, enhancing

0:22

mass, 6 millimeters in the left breast.

0:24

Now, could you see it before?

0:26

It certainly doesn't look actionable to me.

0:28

So this was, um, I think a very good catch again.

0:32

We went back to her mammogram, could not

0:34

find it on a tomosynthesis study, but

0:37

did a targeted ultrasound in this case.

0:39

And there it is.

0:40

You can see it on the far right.

0:42

A small round mass, very posterior

0:44

when she's lying supine, obviously.

0:46

And this was an invasive

0:47

ductal carcinoma, ERPR positive.

0:51

Here's another one.

0:53

This is a 70-year-old with extremely dense

0:55

breasts, negative mammo, screening ultrasound

0:59

actually had been performed five months prior.

1:02

Look at the mass.

1:03

Interesting, huh?

1:04

The second round abbreviated MR.

1:07

This was October 2018, and then November 22, 2020.

1:11

Sorry.

1:12

So about 2 years and nothing on the prior.

1:15

You really don't see a thing.

1:16

And again, remember, she had that screening

1:17

ultrasound 5 months prior to the November 2020 MR.

1:21

R.

1:21

5-millimeter mass by BI-RADS 5.

1:25

Here you go, targeted ultrasound not seen clearly

1:28

on the tomosynthesis, but targeted ultrasound

1:30

probably would have been seen with screening

1:31

ultrasound at this time, but not 5 months prior.

1:33

Curious.

1:34

This was an invasive ductal carcinoma.

1:36

Again, ERPR positive.

1:38

So, subsequent abbreviated MRIs had a

1:41

lower abnormal interpretation rate.

1:44

Higher PPV1, PPV2, um, compared to baseline.

1:48

That makes sense 'cause you've

1:48

got something to compare to.

1:50

Cancer detection was maintained on subsequent

1:53

rounds of abbreviated MR compared to the baseline.

1:56

That's very remarkable.

1:57

And all cancers detected on the subsequent

2:00

exams were still early stage, which is great.